Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of CHF 5993 versus beclometasone + formoterol in uncontrolled asthma
CTR20261294Phase 3Active
- Sponsor
- ---/ 凯西医药咨询（上海）有限公司
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of beclometasone dipropionate/formoterol fumarate/glycopyrronium, beclomethasone dipropionate, formoterol, glycopyrronium in asthma, sponsored by ---/ 凯西医药咨询（上海）有限公司. Started Jun 2026; status: active.
02
Drugs
beclometasone dipropionate/formoterol fumarate/glycopyrroniumbeclomethasone dipropionateformoterolglycopyrronium
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20261294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261294.